Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. (SHE:301617)
China
· Delayed Price · Currency is CNY 48.13
+0.31 (0.65%)
At close: May 13, 2025, 2:57 PM CST
SHE:301617 Revenue
In the year 2024, Shandong Boyuan Pharmaceutical & Chemical had annual revenue of 1.33B CNY with 29.53% growth. Shandong Boyuan Pharmaceutical & Chemical had revenue of 320.24M in the quarter ending March 31, 2025, with 14.89% growth.
Revenue
1.33B
Revenue Growth
+29.53%
P/S Ratio
3.69
Revenue / Employee
n/a
Employees
n/a
Market Cap
4.95B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Kweichow Moutai | 175.72B |
| China Merchants Bank | 295.79B |
| Contemporary Amperex Technology | 366.95B |
| Ping An Insurance (Group) Company of China | 945.67B |
| China Yangtze Power | 85.85B |
| Midea Group | 428.89B |
| Wuliangye Yibin | 91.28B |
| Industrial Bank | 151.04B |